loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 207793 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 IPSEN (1)

filter

01 INJECTABLE, LIPOSOMAL;INTRAVENOUS (1)

filter

01 RX (1)

filter

01 ONIVYDE (1)

filter

01 Yes (1)

URL Supplier Web Content
INJECTABLE, LIPOSO...
EQ 43MG BASE/10ML ...
2015-10-22
207793
ONIVYDE
RX
Yes
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 207793

Looking for FDA Orange Book APPLICATION 207793 1

19

Ipsen, based in France, is a pharmaceutical company.

One of their notable products is IRINOTECAN HYDROCHLORIDE, with a corresponding application number 207793.

Regulatory Information RX

With a dosage strength EQ 43MG BASE/10ML (EQ 4.3MG BASE/ML)

Dosage Form Route INJECTABLE, LIPOSOMAL; INTRAVENOUS

Reference Listed Drug Yes

Approved since 2015-10-22

Post Enquiry
POST ENQUIRY